Portal de investigación
HEALTH CARE ASSOCIATED PNEUMONIA (HCAP):MICROBIAL AETIOLOGY, RISK FACTORS AND PROGNOSTIC
Datos básicos
- NumeroConcesion:
- PI08/0123
- Año inicial:
- 2009
- Año final:
- 2011
Objetivos del proyecto
FINALIZADO
Documentos
- No hay documentos
Participantes
-
Rosario Menéndez Villanueva
Investigador Principal
-
Paula Ramírez Galleymore
Investigador
-
Soledad Reyes Calzada
Investigador
-
José Miguel Sahuquillo Arce
Investigador
-
José Manuel Vallés Tarazona
Investigador
Grupos
-
Infecciones Respiratorias
Investigador Principal
Raúl Méndez Ocaña
Financiadores
Resultados del Proyecto
INVESTIGACIÓN Y FORMACIÓN EN MEDICINA INTENSIVA
ÁLVARO CASTELLANOS ORTEGA, PAULA RAMÍREZ GALLEYMORE
Capítulo de un Libro. 2017
[Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU].
Estella, Angel; (...); Zaragoza, Rafael
Article. 10.1016/j.medin.2021.04.007. 2021
[Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units].
Vidal-Cortes, Pablo; (...); Crespo, Rafael Zaragoza
Article. 10.1016/j.medin.2021.08.011. 2021
A surface plasmon resonance based approach for measuring response to pneumococcal vaccine.
Garrido-Jareño M; (...); Pineda-Lucena A
Article. 10.1038/s41598-021-85958-0. 2021
Acceptance and validity of the methods used to implement a competency based medical education programme in an Intensive Care Department of a teaching referral center.
Castellanos-Ortega, A.; (...); Garcia-Ros, R.
Article. 10.1016/j.medin.2019.12.007. 2021
Acceptance and validity of the methods used to implement a competency based medical education programme in an Intensive Care Department of a teaching referral center.
Castellanos-Ortega A; (...); García-Ros R
Article. 10.1016/j.medine.2019.12.011. 2021
Actinotignum schaalii infection: Challenges in diagnosis and treatment.
Sahuquillo-Arce JM; (...); López-Hontangas JL
Article. 10.1016/j.heliyon.2024.e28589. 2024
Acute and sustained endothelial damage in COVID-19
Mendez, Raul; (...); Menendez, Rosario
Meeting Abstract. 10.1183/13993003.congress-2021.OA3966. 2021
Acute and Sustained IL-17a Response in Bronchiectasis Exacerbations as Marker of Chronic Inflammation
Mendez, R.; (...); Menendez, R.
Meeting Abstract. 2020
Acute and sustained increase in endothelial biomarkers in COVID-19.
Méndez R; (...); Menéndez R
Article. 10.1136/thoraxjnl-2020-216797. 2021
Acute cellular rejection versus recurrent hepatitis C after liver transplantation: Clinical and pathological features driving a rational diagnostic approach
de la Peña-Moral JM; (...); Parrilla P
Article. 10.1111/hepr.12369. 2015
Acute exacerbation of bronchiectasis and the impact on the duration of antibiotic therapy
Oscanoa Huaman, Patricia Elena; (...); Torres Marti, Antoni
Meeting Abstract. 10.1183/13993003.congress-2019.PA2866. 2019
Acute Exacerbations Of COPD And COPD Patients With Community-Acquired Pneumonia: Characteristics, Systemic Inflammatory Response And Outcomes
Huerta, A.; (...); Torres, A.
Article. 2013
Acute respiratory distress syndrome due to COVID-19. Clinical and prognostic features from a medical Critical Care Unit in Valencia, Spain.
Ramírez P; (...); Castellanos Á
Article. 10.1016/j.medin.2020.06.015. 2021
Age-related risk factors for bacterial aetiology in community-acquired pneumonia
Sahuquillo-Arce JM; (...); Torres A
Article. 10.1111/resp.12851. 2016
An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital
Ruiz-Gaitan, A; (...); Peman, J
Article. 10.1111/myc.12781. 2018
ANALYSIS OF BIOFILM IN EXTERNAL VENTRICULAR DRAINAGE. RELATIONSHIP TO INFECTIOUS COMPLICATIONS. PRELIMINARY RESULTS
Ramirez, P.; (...); Calleja, I.
Article. 2009
Analysis of treatment failure with standardand high dose of tigecycline in critically ill patients with multidrug resistant bacteria.
JESÚS RUIZ RAMOS; (...); PAULA RAMÍREZ GALLEYMORE
Article. 2017
Antibiotic Compliance And Timing In Community-Acquired Pneumonia With Sepsis
Menendez, R.; (...); Ruiz, J.
Article. 2011
Antibiotic choice, route and duration: minimising the harm associated with antibiotics
Menendez, R, Montull, B, Mendez, R
Article. 10.1183/1025448x.10004113. 2014
Anti-endotoxin antibodies consumption in cardiovascular collapse: Pathophysiological concerns.
Villarreal, E.; (...); Vila, J.
Article. 10.1016/j.medine.2022.04.019. 2022
Antimicrobial Pharmacokinetics and Pharmacodynamics in Critical Care: Adjusting the Dose in Extracorporeal Circulation and to Prevent the Genesis of Multiresistant Bacteria.
Ruiz-Ramos, Jesus, Gras-Martin, Laura, Ramirez, Paula
Article. 10.3390/antibiotics12030475. 2023
Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP.
Cercenado, Emilia; (...); Retamar-Gentil, Pilar
Practice Guideline. 10.1016/j.eimce.2022.05.013. 2023
Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP
Cercenado, Emilia; (...); Retamar-Gentil, Pilar
Editorial Material. 10.1016/j.eimc.2022.05.005. 2023
Antimicrobial stewardship programme implementation in a medical ward
Ruiz, J; (...); Poveda, JL
Article. 2018
Antimicrobial stewardship programme in critical care medicine: A prospective interventional study
Ruiz, J; (...); Catellanos, A
Article. 10.1016/j.medin.2017.07.002. 2018
Antimicrobial stewardship programs in the critical care setting
Ruiz-Ramos J, Ramirez P
Editorial Material. 10.1016/j.medin.2016.04.010. 2016
Antimicrobial stewardship programs in the intensive care unit in patients with infections caused by multidrug-resistant gram-negative bacilli
Ramos, J. Ruiz, Galleymore, P. Ramirez
Article. 10.1016/j.medin.2022.07.007. 2023
Antimicrobial stewardship programs in the Intensive Care Unit in patients with infections caused by multidrug-resistant Gram-negative bacilli.
Ruiz-Ramos J, Ramírez P
Article. 10.1016/j.medine.2022.09.004. 2022
Antisepsis for blood culture extraction. Blood culture contamination rate
Galleymore, PR, Sahuquillo, MG
Article. 10.1016/j.medin.2018.08.007. 2019
Assessment of the in vivo formation of biofilm on external ventricular drainages.
Ramírez P; (...); Bonastre J
Article. 10.1007/s10096-013-1895-8. 2013
Autoclave sterilization of an in-house 3D-printed polylactic acid piece: biological safety and heat-induced deformation.
Ferràs-Tarragó J; (...); Baixauli-García F
Article. 10.1007/s00068-021-01672-6. 2021
BACTERAEMIC PNEUMOCOCCAL PNEUMONIA AND SARS-CoV-2 PNEUMONIA: DIFFERENCES AND SIMILARITIES.
Fernández LS; (...); Jorge RZ
Article. 10.1016/j.ijid.2021.11.023. 2022
Bacteremia in non-HIV community acquired pneumonia
Cilloniz, Catia; (...); Menendez, Rosario
Article. 2013
Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia.
Cillóniz C; (...); Torres A
Article. 10.1016/j.jinf.2012.04.009. 2012
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Iglesias Gómez R; (...); Poveda Andrés JL
Article. 10.1136/ejhpharm-2021-002741. 2021
Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia
Menendez, Rosario; (...); Torres, Antoni
Article. 10.1038/s41598-024-62718-4. 2024
Beyond the Pandemic: The Value of Antimicrobial Stewardship
Kanj, Souha S., Ramirez, Paula, Rodrigues, Camilla
Article. 10.3389/fpubh.2022.902835. 2022
BIOFILM FORMATION IN ENDOTRACHEAL TUBES IN AN ICU ENDEMIC FOR ACINETOBACTER BAUMANII
Gil-Perotin, S.; (...); Ramirez, P.
Article. 2009
Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study
Póvoa P; (...); Artigas A
Article. 10.1186/s13613-016-0134-8. 2016
Biomarkers and community-acquired pneumonia: tailoring management with biological data.
Torres A; (...); Menéndez R
Article. 10.1055/s-0032-1315638. 2012
Biomarkers As Predictors Of Early And Long-Term Cardiovascular Events In Community-Acquired Pneumonia. Preliminary Results
Mendez, R.; (...); Menendez, R.
Meeting Abstract. 2016
Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia.
Menéndez R; (...); Torres A
Article. 10.1136/thx.2008.105312. 2009
Biomarkers in Community-Acquired Pneumonia (Cardiac and Non-Cardiac).
Méndez R, Aldás I, Menéndez R
Review. 10.3390/jcm9020549. 2020
Biomarkers in pulmonary infections: a clinical approach.
Povoa, Pedro; (...); Kalil, Andre C
Article. 10.1186/s13613-024-01323-0. 2024
Biomarkers in the ICU: less is more? Yes.
Huang, David T., Ramirez, Paula
Editorial Material. 10.1007/s00134-020-06049-8. 2021
Biomarkers kinetics in the assessment of ventilator-associated pneumonia response to antibiotics - results from the BioVAP study
Povoa, P; (...); Artigas, A
Article. 10.1016/j.jcrc.2017.05.007. 2017
Blood culture contamination rate in an intensive care setting: Effectiveness of an education-based intervention
Ramirez P; (...); Bonastre J
Article. 10.1016/j.ajic.2015.04.183. 2015
Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes.
Wang X; (...); Barreiro E
Article. 10.3390/biomedicines10051044. 2022
Bronchiectasis and Multidrug-resistant Microorganisms: The Ideal Niche?
Mendez, R, Amara, I, Menendez, R
Editorial Material. 10.1016/j.arbres.2018.02.018. 2018
Capnophilic Enterobacteriaceae
Sahuquillo-Arce, JM; (...); Lopez-Hontangas, JL
Article. 10.1016/j.diagmicrobio.2017.01.010. 2017
Cardiovascular Events during and after Bronchiectasis Exacerbations and Long-Term Mortality.
Méndez R; (...); Menéndez R
Article. 10.1016/j.chest.2021.10.013. 2021
Cefiderocol pharmacokinetics in critically ill patients undergoing ECMO support.
Marín-Cerezuela M; (...); Ramirez P
Letter. 10.1186/s13054-024-05126-4. 2024
Ceftaroline versus standard therapy for pneumococcal meningitis in critically ill patients.
Martin-Cerezuela, M; (...); Galleymore, P R
Article. 10.1016/j.medin.2021.05.011. 2021
Ceftaroline versus standard therapy for pneumococcal meningitis in critically ill patients.
Martín-Cerezuela M; (...); Galleymore PR
Article. 10.1016/j.medine.2021.05.007. 2022
Ceftolozane/Tazobactam Dosing Requirements Against Pseudomonas aeruginosa Bacteremia.
Ruiz J; (...); Ramirez P
Article. 10.1177/1559325819885790. 2020
Clinical characteristics, risk factors and management of patients with inflammatory bowel disease and hidradenitis suppurativa: a nationwide multicenter study of the GETECCU ENEIDA registry
Madero Velazquez, L.; (...); Gutierrez-Casbas, A.
Meeting Abstract. 2024
Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients.
Pemán J; (...); Pontón J
Article. 10.1186/1471-2334-11-60. 2011
Clinical Factors Associated with a Shorter or Longer Course of Antibiotic Treatment in Patients with Exacerbations of Bronchiectasis: A Prospective Cohort Study.
Scioscia G; (...); Torres A
Article. 10.3390/jcm8111950. 2019
Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients.
Zaragoza R; (...); Candida albicans Germ Tube Antibody Detection in Critically Ill Patients (CAGTAU
Article. 10.1111/j.1469-0691.2009.02794.x. 2009
Clinical Stability and Biomarkers in Community-Acquired Pneumonia.
Menendez, R.; (...); Torres, A.
Article. 2009
Clinical Use of Biomarkers in the Diagnosis and Management of CAP
Article. 10.1016/j.ijid.2010.02.2191. 2010
Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial
Cisneros, JM; (...); Magic Bullet Working Grp WP1
Article. 10.1186/s13054-019-2627-y. 2019
Combatting resistance in intensive care: the multimodal approach of the Spanish ICU "Zero Resistance" program
Montero JG; (...); García MS
Review. 10.1186/s13054-015-0800-5. 2015
Community-Acquired Pneumonia Patients at Risk for Early and Long-term Cardiovascular Events Are Identified by Cardiac Biomarkers
Menendez, R; (...); Torres, A
Article. 10.1016/j.chest.2019.06.040. 2019
Community-acquired pneumonia with severe sepsis: Etiology and prognosis
Montull, Beatriz; (...); Menendez, Rosario
Article. 2013
Community-Acquired Pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) Guidelines. 2020 Update
MENENDEZ, R; (...); Torres, A
Review. 10.1016/j.arbres.2020.01.014. 2020
Comorbidities And Initial Severity In Community-Acquired Pneumonia (cap)
Menendez, R.; (...); Torres, A.
Meeting Abstract. 2015
Comparison of real-time and droplet digital PCR to detect and quantify SARS-CoV-2 RNA in plasma.
Tedim AP; (...); Torres A
Article. 10.1111/eci.13501. 2021
Compliance with guidelines-recommended processes in pneumonia: impact of health status and initial signs.
Menéndez R; (...); Ruiz-Manzano J
Article. 10.1371/journal.pone.0037570. 2012
Corticosteroids and pneumonia - targeting the ideal candidate
Menendez, R, Amara-Elori, I, Mendez, R
Editorial Material. 10.1080/17476348.2018.1502085. 2018
Cost Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccination Program in Chronic Obstructive Pulmonary Disease Patients Aged 50+Years in Spain
Rodríguez González-Moro JM; (...); Antoñanzas F
Article. 10.1007/s40261-015-0345-z. 2016
Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units
Ruiz-Ramos, J; (...); Ramirez, P
Article. 10.1080/13696998.2017.1311903. 2017
COST-EFFECTIVENESS OF A 13-VALENT CONJUGATE PNEUMOCOCCAL VACCINATION PROGRAM IN COPD PATIENTS AGED 50+YEARS IN SPAIN
Rodríguez-GonzálezMoro JM; (...); Antoñanzas F
Meeting Abstract. 10.1016/j.jval.2015.09.1424. 2015
COVID-19 in young and middle aged adults. Predictors of poor evolution and clinical differences
Tabernero Huguet, Eva; (...); Zalacain Jorge, Rafael
Meeting Abstract. 10.1183/13993003.congress-2021.OA88. 2021
COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences
Tabernero E; (...); Zalacain R
Article. 10.1007/s15010-021-01684-9. 2021
COVID-19 Patients Benefitting From Remdesivir for Improved Survival: A Neural Network-Based Approach.
Garcia-Vidal, Carolina; (...); Soriano, Alex
Article. 10.1002/jmv.70276. 2025
C-Reactive Protein at Discharge, Diabetes Mellitus and >= 1 Hospitalization During Previous Year Predict Early Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Crisafulli E; (...); Menéndez R
Article. 10.3109/15412555.2014.933954. 2015
C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON).
Posadas T; (...); Martinez-García MA
Article. 10.1016/j.arbres.2019.12.017. 2021
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations.
Aliberti S; (...); Chalmers JD
Article. 10.1016/S2213-2600(21)00277-0. 2021
Current aspects in sepsis approach. Turning things around
Javier Candel, Francisco; (...); Vidal, Pablo
Review. 2018
Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults.
Vidal-Cortes, Pablo; (...); Zaragoza, Rafael
Review. 10.3390/antibiotics11091160. 2022
Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia.
Menéndez R; (...); Torres A
Article. 10.1378/chest.11-1446. 2012
Characterization of community acquired pneumonia (CAP) with severe sepsis at diagnosis
Veiga, Beatriz Montull; (...); Ruiz-Manzano, Juan
Article. 2012
Daily bathing strategies and cross-transmission of multidrug-resistant organisms: Impact of chlorhexidine-impregnated wipes in a multidrug-resistant gram-negative bacteria endemic intensive care unit
Ruiz, J; (...); Castellanos-Ortega, A
Article. 10.1016/j.ajic.2017.06.029. 2017
Decolonization strategies against multidrug resistant organisms in the ICU.
Póvoa P, Ramirez P, Blot S
Editorial Material. 10.1007/s00134-024-07360-4. 2024
Detection and treatment of Candida auris in an outbreak situation: risk factors for developing colonization and candidemia by this new species in critically ill patients
Ruiz-Gaitan, Alba; (...); Peman, Javier
Article. 10.1080/14787210.2019.1592675. 2019
Determination of meropenem in endotracheal tubes by in-tube solid phase microextraction coupled to capillary liquid chromatography with diode array detection
Hakobyan, L; (...); Campins-Falco, P
Article. 10.1016/j.jpba.2018.01.006. 2018
Diagnosing external ventricular drain-related ventriculitis by means of local inflammatory response: soluble triggering receptor expressed on myeloid cells-1
Gordon M; (...); Bonastre J
Article. 10.1186/s13054-014-0567-0. 2014
Diagnosis and treatment of catheter-related bloodstream infection: Clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC).
Chaves F; (...); Valles J
Article. 10.1016/j.medin.2017.09.012. 2018
Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in patients with acute respiratory distress syndrome and abdominal diseases: a preliminary observational study.
Ramírez P; (...); Ramírez P
Article. 10.1186/cc10015. 2011
Differences in Nutritional Status and Inflammatory Biomarkers between Female and Male Patients with Bronchiectasis: A Large-Cohort Study
Wang, XJ; (...); Barreiro, E
Article. 10.3390/biomedicines9080905. 2021
Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza.
Almansa R; (...); Bermejo-Martin JF
Article. 10.1186/1471-2334-11-232. 2011
Early and Late Cardiovascular Events in Patients Hospitalized for Community-Acquired Pneumonia.
Aldás I; (...); Grupo NEUMONAC
Article. 10.1016/j.arbres.2019.10.009. 2019
Early profiling of low-risk SARS-CoV-2 pneumonia for ward allocation
Mendez, Raul; (...); Menendez, Rosario
Meeting Abstract. 10.1183/13993003.congress-2021.PA3659. 2021
Early recognition of low-risk SARS-CoV-2 pneumonia: A model validated with initial data and IDSA/ATS minor criteria.
Menendez, Rosario; (...); Torres, Antoni
Article. 10.1016/j.chest.2022.05.013. 2022
Effect of Corticosteroids on C-Reactive Protein in Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: The Effect of Lymphopenia.
Torres A; (...); Niederman MS
Article. 10.3390/jcm8091461. 2019
Effect of corticosteroids on inflammatory markers in patients with severe cap and high inflammatory response according to presence of lymphopenia
Ceccato, Adrian; (...); Torres, Antoni
Meeting Abstract. 10.1183/13993003.congress-2019.PA2911. 2019
Effect of pharmacokinetic/pharmacodynamic ratio on tigecycline clinical response and toxicity in critically ill patients with multidrug-resistant Gram-negative infections
Ruiz, J; (...); Castellanos-Ortega, A
Article. 10.1177/2050312120958897. 2020
Efficacy and Experience of Bacteriophages in Biofilm-Related Infections.
Gordon, Monica, Ramirez, Paula
Article. 10.3390/antibiotics13020125. 2024
Endothelial Biomarkers Are Superior to Classic Inflammatory Biomarkers in Community-Acquired Pneumonia.
González-Jiménez P; (...); Méndez R
Article. 10.3390/biomedicines12102413. 2024
Endothelial Damage, Neutrophil Extracellular Traps and Platelet Activation in COVID-19 vs. Community-Acquired Pneumonia: A Case-Control Study.
González-Jiménez P; (...); Menéndez R
Article. 10.3390/ijms241713194. 2023
Epidemiology and clinical description of Chagas disease in Valencia, Spain, from 2010 to 2020
Lozano, Noelia; (...); Calabuig, Eva
Article. 10.1016/j.actatropica.2024.107458. 2024
Epidemiology and clinical features caused by Candida auris in the setting of a prolonged outbreak
Meeting Abstract. 2017
Evaluating the diagnostic performance of Liaison® chemiluminescence assay as screening tool for detection of acute Epstein-Barr infection: A comparative study
Tortosa-Carreres, Jordi; (...); Lopez-Hontangas, Jose Luis
Article. 10.1016/j.diagmicrobio.2023.116167. 2024
Evaluation of the Kinetics of Pancreatic Stone Protein as a Predictor of Ventilator-Associated Pneumonia.
Ceccato, Adrian; (...); Artigas, Antonio
Article. 10.3390/biomedicines11102676. 2023
Executive summary: Diagnosis and Treatment of Catheter-Related Bloodstream Infection: Clinical Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) and the Spanish Society of Intensive Care Medicine and Coronary Units (SEMICYUC)
Chaves, F; (...); Valles, J
Article. 10.1016/j.eimc.2017.10.019. 2018
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2.
Candel, Francisco Javier; (...); On Behalf Of The Modus Investigators Adenda
Article. 10.3390/v15071449. 2023
External Ventricular Drain-Related Ventriculitis Prevention: Standard Preventive Measures Still Work
Letter. 10.1097/CCM.0000000000000285. 2014
Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study
Menendez, R; (...); Torres, A
Article. 10.1186/s12931-017-0659-x. 2017
Factors associated with inflammatory cytokine patterns in community-acquired pneumonia.
Martínez R; (...); Torres A
Article. 10.1183/09031936.00040710. 2011
Factors Associated With One-Year Mortality in Hospitalised Patients With Exacerbated Bronchiectasis.
Scioscia, G.; (...); Torres, A.
Article. 10.1016/j.arbres.2022.04.008. 2022
Factors associated with one-year mortality in hospitalized patients with exacerbation of bronchiectasis
Scioscia, Giulia; (...); Torres, Antoni
Meeting Abstract. 10.1183/13993003.congress-2020.3331. 2020
Four cases of unexpected severe community-acquired pneumonia aetiology: Group A Streptococcus pyogenes disruption
Talavera, Monica; (...); Ramirez, Paula
Letter. 10.1016/j.medin.2023.04.013. 2023
Four cases of unexpected severe community-acquired pneumonia aetiology: Group A Streptococcus pyogenes disruption.
Talavera, Monica; (...); Ramirez, Paula
Case Reports. 10.1016/j.medine.2023.05.004. 2023
From MIC creep to MIC decline: Staphylococcus aureus antibiotic susceptibility evolution over the last 4 years
Ruiz J; (...); Ramirez P
Letter. 10.1016/j.cmi.2016.05.007. 2016
From starting mechanical ventilation to ventilator-associated pneumonia, choosing the right moment to start antibiotic treatment
Ramirez P; (...); Torres A
Article. 10.1186/s13054-016-1342-1. 2016
Fungal co-infection in COVID-19 patients: Should we be concerned?
Pemán J; (...); Quindós G
Review. 10.1016/j.riam.2020.07.001. 2020
Healthcare-associated pneumonia (HCAP): clinical features and biomarkers
Polverino, E.; (...); Torres, A.
Article. 2010
Herpes Zoster Virus: Should Patients With Chronic Respiratory Diseases Be Vaccinated?
Menendez, Rosario, Gonzalez-Jimenez, Paula, Mendez, Raul
Editorial Material. 10.1016/j.arbres.2023.07.012. 2023
Host adaptive immunity deficiency in severe pandemic influenza.
Bermejo-Martin JF; (...); Kelvin D
Article. 10.1186/cc9259. 2010
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians.
Povoa, Pedro; (...); Kalil, Andre C.
Article. 10.1007/s00134-022-06956-y. 2023
IgA level in plasma as a differential factor for influenza infection in severe viral pneumonia
Almansa R; (...); Bermejo-Martin JF
Letter. 10.1016/j.jcv.2013.12.003. 2014
IgG antibody response to pneumococcal-conjugated vaccine (Prevenar®13) in children with immunodeficiency disorders.
Garrido-Jareño M; (...); Pemán-García J
Article. 10.1007/s00430-022-00759-0. 2023
IgM levels in plasma predict outcome in severe pandemic influenza.
Justel M; (...); Bermejo-Martin JF
Article. 10.1016/j.jcv.2013.09.006. 2013
Imbalanced pro- and anti-Th17 responses (IL-17/granulocyte colony-stimulating factor) predict fatal outcome in 2009 pandemic influenza.
Almansa R; (...); Bermejo-Martin JF
Letter. 10.1186/cc10426. 2011
Immune treatment in COVID-19.
Menendez, Rosario; (...); Mendez, Raul
Article. 10.37201/req/s01.14.2022. 2022
Immunological monitoring to prevent and treat sepsis.
Almansa R; (...); Bermejo-Martin JF
Article. 10.1186/cc11922. 2013
Impact of amikacin pharmacokinetic/pharmacodynamic index on treatment response in critically ill patients
Ruiz, J; (...); Castellanos-Ortega, A
Article. 10.1016/j.jgar.2017.09.019. 2018
Impact of an antimicrobial stewardship program on critical haematological patients.
Ruiz-Ramos, J; (...); Ramirez, P
Article. 10.7399/fh.2017.41.4.10709. 2017
Impact of Chronic Bronchial Infection by Staphylococcus aureus on Bronchiectasis.
Garcia Clemente, Marta; (...); Martínez-García MÁ
Article. 10.3390/jcm11143960. 2022
Impact of guidelines on outcome: the evidence.
Martínez R; (...); Menéndez R
Article. 10.1055/s-0029-1202936. 2009
Impact of microbial ecology on accuracy of surveillance cultures to predict multidrug resistant microorganisms causing ventilator-associated pneumonia
Lopez-Ferraz C; (...); Torres A
Article. 10.1016/j.jinf.2014.05.011. 2014
Impact of outdoor air pollution on severity and mortality in COVID-19 pneumonia.
Bronte, O.; (...); Espana, P. P.
Article. 10.1016/j.scitotenv.2023.164877. 2023
Impact of the "Zero Resistance" program on acquisition of multidrug-resistant bacteria in patients admitted to Intensive Care Units in Spain. A prospective, intervention, multimodal, multicenter study.
Álvarez-Lerma F; (...); Martínez-Alonso M
Article. 10.1016/j.medine.2022.12.002. 2023
Impact of the ?Zero Resistance? program on acquisition of multidrug-resistant bacteria in patients admitted to Intensive Care Units in Spain. A prospective, intervention, multimodal, multicenter study
Alvarez-Lerma, Francisco; (...); Martinez-Alonso, Montserrat
Article. 10.1016/j.medin.2022.12.002. 2023
Impact of Time to Intubation on Mortality and Pulmonary Sequelae in Critically Ill COVID-19 Patients: A Prospective Cohort
Gonzalez, J.; (...); Barbe, F.
Meeting Abstract. 2022
Impact of voriconazole plasma concentrations on treatment response in critically ill patients
Ruiz, J; (...); Ramirez, P
Article. 10.1111/jcpt.12817. 2019
Impact on in-hospital mortality of Ceftaroline versus standard of care in Community-Acquired Pneumonia: A Propensity Matched Analysis
Campos, Catia Cilloniz; (...); Soriano, Alex
Meeting Abstract. 10.1183/13993003.congress-2021.PA1753. 2021
Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis.
Cilloniz, Catia; (...); Soriano, Alex
Article. 10.1007/s10096-021-04378-0. 2022
Implication of Haemodiafiltration Flow Rate on Amikacin Pharmacokinetic Parameters in Critically Ill Patients
Ruiz-Ramos, J; (...); Ramirez, P
Article. 10.1159/000478969. 2018
Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept.
Gil-Perotin S; (...); Bonastre J
Article. 10.1186/cc11357. 2012
In vitro study of antimicrobial activity on Klebsiella Pneumoniae biofilms in endotracheal tubes
Ruiz, J; (...); Ramirez, P
Article. 10.1080/1120009X.2019.1601801. 2019
Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection.
García-Ortega A; (...); Martínez-García MÁ
Article. 10.1016/j.jinf.2021.01.003. 2021
Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia.
Moret I; (...); Menéndez R
Article. 10.1183/09031936.00190410. 2011
Individualised antimicrobial dosing in critically ill patients undergoing continuous renal replacement therapy: focus on total drug clearance
Ruiz, J; (...); Ramirez, P
Article. 10.1136/ejhpharm-2016-001114. 2018
Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia.
Ramírez P; (...); Torres A
Article. 10.1097/CCM.0b013e3182257445. 2011
Influence of antibiotic pressure on multi-drug resistant Klebsiella pneumoniae colonisation in critically ill patients
Ruiz, J; (...); Ramirez, P
Article. 10.1186/s13756-019-0484-8. 2019
Influence of environmental conditions and pollution on the incidence of Streptococcus pneumoniae infections.
Sahuquillo-Arce JM; (...); López-Hontangas JL
Article. 10.1183/23120541.00014-2017. 2017
Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: A prospective clinical study
Ferrer M; (...); Menéndez R
Article. 10.1111/resp.12324. 2014
Inhaled Corticosteroids Do Not Influence the Early Inflammatory Response and Clinical Presentation of Hospitalized Subjects With COPD Exacerbation
Crisafulli E; (...); Torres A
Article. 10.4187/respcare.03036. 2014
Initial and Residual Cardiovascular Damage Remaining at Day 30 in Community-acquired Pneumonia
Ocana, R. Mendez; (...); Menendez, R.
Meeting Abstract. https://doi.org/10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A6241. 2024
Initial Antifungal Strategy Reduces Mortality in Critically Ill Patients With Candidemia: A Propensity Score-Adjusted Analysis of a Multicenter Study*
Garnacho-Montero, J; (...); Garcia-Garmendia, JL
Article. 10.1097/CCM.0000000000002867. 2018
Initial experience of use of tolvaptan in critically ill patients with fluid overload
Ruiz-Ramos J; (...); Ramirez P
Article. 10.1111/jcpt.12255. 2015
Initial Inflammatory Profile in Community-acquired Pneumonia Depends on Time since Onset of Symptoms
Mendez, R; (...); Torres, A
Article. 10.1164/rccm.201709-1908OC. 2018
Initial management of pneumonia and sepsis: factors associated with improved outcome.
Menéndez R; (...); Ruiz-Manzano J
Article. 10.1183/09031936.00188710. 2012
Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection.
Paquette SG; (...); Kelvin DJ
Article. 10.1371/journal.pone.0038214. 2012
Intestinal microbiota in the critical patient. A positive approach through the contribution of symbiotics
Editorial Material. 10.1016/j.medcli.2013.12.007. 2014
Invasive aspergillosis in critically ill patients
Ramirez, P, Garnacho-Montero, J
Review. 10.1016/j.riam.2018.07.001. 2018
Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?
Mendez, Raul; (...); NEUMONAC and RECOVID
Article. 10.3389/fmed.2023.1236142. 2023
Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients.
González J; (...); Barbé F
Article. 10.1016/j.arbres.2022.12.017. 2023
Kinetic Patterns of Candida albicans Germ Tube Antibody in Critically Ill Patients: Influence on Mortality
Zaragoza, Rafael; (...); Ponton, Jose
Article. 10.1128/CVI.00183-09. 2009
Kinetics Of Biomarkers Depends On Onset Of Symptoms In Community-Acquired Pneumonia
Mendez, R; (...); Torres, A
Meeting Abstract. 2017
K-Means Clustering Identifies Diverse Clinical Phenotypes in COVID-19 Patients: Implications for Mortality Risks and Remdesivir Impact.
Garcia-Vidal C; (...); Soriano A
Article. 10.1007/s40121-024-00938-x. 2024
Late Breaking Abstract - Incidence, risk factors and thrombotic load of pulmonary embolism in patients hospitalized with COVID-19
Bekki, Amina; (...); Angel Martinez-Garcia, Miguel
Meeting Abstract. 10.1183/13993003.congress-2021.OA2597. 2021
Long-term Mortality in COVID-19 and Community-Acquired Pneumonia: A One-year Follow-up Study
Ocana, R. Mendez; (...); NEUMONAC RECOVID
Meeting Abstract. 2023
Long-term neuropsychiatric outcomes in COVID-19 survivors: A 1-year longitudinal study.
Mendez, Raul; (...); Menendez, Rosario
Letter. 10.1111/joim.13389. 2022
Lower Respiratory Tract Infection and Short-Term Outcome in Patients With Acute Respiratory Distress Syndrome.
Zampieri FG; (...); TAVeM study group
Article. 10.1177/0885066618772498. 2018
Lung inflammatory pattern and antibiotic treatment in pneumonia
Lorenzo MJ; (...); Menéndez R
Article. 10.1186/s12931-015-0165-y. 2015
Lymphocyte Subpopulations in Community-Acquired Pneumonia: Role of Cell-Mediated Immunity
Mendez, R; (...); Menendez, R
Meeting Abstract. 2018
Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality
Bermejo-Martin, JF; (...); NEUMONAC group
Article. 10.1016/j.ebiom.2017.09.023. 2017
Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection
Bermejo-Martin, JF; (...); Torres, A
Letter. 10.1016/j.jinf.2020.02.029. 2020
Lymphopenic community-acquired pneumonia is associated with a dysregulated immune response and increased severity and mortality
Mendez, R; (...); Torres, A
Article. 10.1016/j.jinf.2019.04.006. 2019
Machine-Learning Model for Mortality Prediction in Patients with Community-acquired Pneumonia: Development and validation study.
Cilloniz, Catia; (...); Torres, Antoni
Article. 10.1016/j.chest.2022.07.005. 2022
Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU.
Estella, A; (...); Zaragoza, R
Article. 10.1016/j.medine.2021.08.013. 2021
Measures to prevent nosocomial infections during mechanical ventilation.
Ramirez P, Bassi GL, Torres A
Article. 10.1097/MCC.0b013e32834ef3ff. 2012
Microbial aetiology and outcomes of CAP in bronchiectatic patients
Polverino, Eva; (...); Torres, Antoni
Article. 2013
Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study.
Polverino E; (...); Rello J
Article. 10.1136/thoraxjnl-2013-203828. 2013
MINIMALLY INVASIVE VERSUS OPEN HYSTERECTOMY IN HIGH-RISK ENDOMETRIAL CANCER: A PROPENSITY SCORE MATCHING ANALYSIS
Segarra Vidal, B.; (...); Ramirez, P.
Meeting Abstract. 10.1136/ijgc-2021-ESGO.206. 2021
miR-146a is a pivotal regulator of neutrophil extracellular trap formation promoting thrombosis.
Arroyo AB; (...); Martínez C
Article. 10.3324/haematol.2019.240226. 2021
Monographic: antisepsis in the critical patient Introduction
Ramirez, P., Nuvials, X., Diaz, E.
Editorial Material. 10.1016/j.medin.2018.07.018. 2019
Neutrophil Extracellular Traps and Platelet Activation for Identifying Severe Episodes and Clinical Trajectories in COVID-19
González-Jiménez P; (...); Menéndez R
Article. 10.3390/ijms24076690. 2023
Neutrophil extracellular traps levels are associated to severity and complications in community-acquired pneumonia
Jimenez, PG; (...); MENENDEZ, R
Meeting Abstract. 10.1183/13993003.congress-2020.2341. 2020
New evidence in severe pneumonia: meropenem-vaborbactam.
Forteza Guillot, Maria, Martin Cerezuela, Maria, Ramirez, Paula
Article. 10.37201/req/s01.10.2022. 2022
New Sepsis Definition (Sepsis-3) and Community-acquired Pneumonia Mortality A Validation and Clinical Decision-Making Study
Ranzani, OT; (...); Torres, A
Article. 10.1164/rccm.201611-2262OC. 2017
New therapy options for MRSA with respiratory infection/pneumonia.
Ramirez P, Fernández-Barat L, Torres A
Article. 10.1097/QCO.0b013e3283509cfa. 2012
Nosocomial infections in intensive care units
Zaragoza R, Ramírez P, López-Pueyo MJ
Article. 10.1016/j.eimc.2014.02.006. 2014
Obtaining patient phenotypes in SARS-CoV-2 pneumonia, and their association with clinical severity and mortality
Garcia-Garcia, Fernando; (...); Jorge, Rafael Zalacain
Article. 10.1186/s41479-024-00132-0. 2024
Outbreak of Candida auris in Spain: A comparison of antifungal activity by three methods with published data
Ruiz-Gaitan, AC; (...); Peman, Javier
Article. 10.1016/j.ijantimicag.2019.02.005. 2019
OUTCOMES FOLLOWING OPEN RADICAL HYSTERECTOMY AFTER IMPLEMENTATION OF AN ENHANCED RECOVERY AFTER SURGERY (ERAS) PROGRAM
Agusti, N.; (...); Ramirez, P.
Meeting Abstract. 10.1136/ijgc-2021-ESGO.67. 2021
Patients with Stable and Acute Exacerbation of Bronchiectasis Present Increased Platelet Activation
Mendez, R; (...); Menendez, R
Meeting Abstract. 2019
Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19
Figueira-Goncalves, Juan Marco; (...); Menendez, Rosario
Article. 10.2147/COPD.S428316. 2023
PES Score validation in a multicenter Cohort of patients with community-acquired pneumonia
Ceccato, Adrian; (...); Torres, Antoni
Meeting Abstract. 10.1183/13993003.congress-2019.OA3305. 2019
Pharmacokinetics of Amikacin in Critical Care Patients on Extracorporeal Device
Ruiz-Ramos, J; (...); Castellanos-Ortega, A
Article. 10.1097/MAT.0000000000000689. 2018
Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity
Wang, XJ; (...); Barreiro, E
Article. 10.3390/ijerph18168431. 2021
Platelet activation is boosted early in community-acquired pneumonia and sustained until 30 days later
Mendez, R; (...); Menendez, R
Meeting Abstract. 10.1183/13993003.congress-2018.PA2633. 2018
Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016-2020: The CAPA Study
Menendez, Rosario; (...); Gessner, Bradford D.
Article. 10.3390/microorganisms11112781. 2023
Pneumonia presenting with organ dysfunctions: Causative microorganisms, host factors and outcome
Menéndez R; (...); Torres A
Article. 10.1016/j.jinf.2016.08.001. 2016
Pneumonic and non-pneumonic exacerbations in bronchiectasis: Clinical and microbiological differences
Polverino, E; (...); Torres, A
Article. 10.1016/j.jinf.2018.04.006. 2018
Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics.
Huerta A; (...); Torres A
Article. 10.1378/chest.13-0488. 2013
Pneumonic and non-pneumonic exacerbations of COPD: Systemic inflammatory response and clinical characteristics
Huerta, Arturo; (...); Torres, Antoni
Article. 2013
Possible transmission of plasmodium malariae through liver transplantation: Diagnosis with a Sysmex XN-20 hematology analyzer.
Martinez-Cerezuela, Andreu; (...); Contreras-Martinez, Maria Teresa
Article. 10.1016/j.parint.2024.102955. 2024
Practical document on the management of hyponatremia in critically ill patients
Porcar, MJB; (...); Herrera-Gutierrez, ME
Article. 10.1016/j.medin.2018.12.002. 2019
Predicting In-Hospital Treatment Failure (<= 7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids
Crisafulli E; (...); Menéndez R
Article. 10.3109/15412555.2015.1057276. 2016
Predicting treatment failure in patients with community acquired pneumonia: a case-control study
Martin-Loeches I; (...); Torres A
Article. 10.1186/1465-9921-15-75. 2014
Predictors of Severe Sepsis among Patients Hospitalized for Community-Acquired Pneumonia
Montull B; (...); NAC Calidad Group
Article. 10.1371/journal.pone.0145929. 2016
Predictors of severe sepsis among patients hospitalized for community-acquired pneumonia.
Article. 2016
Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study.
Benítez ID; (...); Barbé F
Article. 10.1016/j.lanepe.2022.100422. 2022
Proinflamatory and Autoimmune-like Cytokines Profiles in Severe Pandemic Influenza H1N1 Disease
Almansa, Raquel; (...); Kelvin, David
Article. 10.1016/j.clim.2010.03.326. 2010
Prospective cohort study on hospitalised patients with suspected urinary tract infection and risk factors por multidrug resistance.
Garcia-Bustos V; (...); Lletí MS
Article. 10.1038/s41598-021-90949-2. 2021
Recomendaciones GEMICOMED/GEIRAS-SEIMC para el manejo de las infecciones y colonizaciones por Candida auris.
Alastruey-Izquierdo A; (...); en nombre de GEMICOMED GEIRAS-SEIMC
Abstract of Published Item. 10.1016/j.riam.2019.06.001. 2019
Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units.
Vidal-Cortés P; (...); Zaragoza Crespo R
Practice Guideline. 10.1016/j.medine.2021.11.019. 2022
Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients
Hernandez-Tejedor, A; (...); Herrera-Gutierrez, ME
Article. 10.1016/j.medin.2017.03.004. 2017
Reduced Diffusion Capacity in COVID-19 Survivors.
Mendez, Raul; (...); Menendez, Rosario
Article. 10.1513/AnnalsATS.202011-1452RL. 2021
Reply to "Dual Antibiotic Therapy for Outpatient Management of Community-Acquired Pneumonia?"
Menéndez R, Méndez R, Torres A
Letter. 10.1016/j.arbres.2020.06.016. 2020
Reply to: "ormothermic regional perfusion - What is the benefit?''
Hessheimer, AJ; (...); Fondevila, C
Letter. 10.1016/j.jhep.2019.04.005. 2019
Research in community-acquired pneumonia: the next steps
Torres, A, Martin-Loeches, I, Menendez, R
Editorial Material. 10.1007/s00134-017-4774-4. 2017
Residual pulmonary infiltrates, symptoms and diffusion impairment at one-year after severe COVID-19 infection have different associated factors.
Menendez, Rosario; (...); Torres, Antoni
Article. 10.1111/joim.13642. 2023
Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms
Martin-Loeches I; (...); Ferrer M
Article. 10.1016/j.jinf.2014.10.004. 2015
RIBRON: The spanish Online Bronchiectasis Registry. Characterization of the First 1912 Patients.
Martinez-García MA; (...); Olveira C
Article. 10.1016/j.arbres.2019.12.021. 2021
Risk Factors Associated to Cardiovascular Events after Bronchiectasis Exacerbation: A Prospective Study
Olmos, LF; (...); MENENDEZ, R
Meeting Abstract. 10.1183/13993003.congress-2020.4100. 2020
Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations
Menendez, R; (...); Torres, A
Article. 10.1186/s12879-017-2754-5. 2017
Risk factors of A/H1N1 etiology in pneumonia and its impact on mortality.
Reyes S; (...); Menéndez R
Article. 10.1016/j.rmed.2011.04.011. 2011
Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease: a cohort study of the ENEIDA registry
Calafat, M; (...); Domenech, E
Meeting Abstract. 10.1093/ecco-jcc/jjy222.561. 2019
Security of 3D-printed polylactide acid piece sterilization in the operating room: a sterility test.
Ferràs-Tarragó J; (...); Baixauli-García F
Article. 10.1007/s00068-020-01564-1. 2021
Sensitivity, Specificity, and Positivity Predictors of the Pneumococcal Urinary Antigen Test in Community-Acquired Pneumonia.
Molinos L; (...); Torres A
Article. 10.1513/AnnalsATS.201505-304OC. 2015
Sepsis-3 In Community-Acquired Pneumonia: A Clinical Decision-Making Study
Ranzani, OT; (...); Torres, A
Meeting Abstract. 2017
SEPTIC PARTICIPATION IN CARDIOGENIC SHOCK: EXPOSURE TO BACTERIAL ENDOTOXIN
Ramirez, P; (...); Vila, J
Article. 10.1097/SHK.0000000000000798. 2017
Severe community-acquired Streptococcus pneumoniae bacterial meningitis: clinical and prognostic picture from the intensive care unit.
Martín-Cerezuela M; (...); Ramírez-Galleymore P
Article. 10.1186/s13054-023-04347-3. 2023
Severity and outcomes of community acquired pneumonia in asthmatic patients
Terraneo S; (...); Torres A
Article. 10.1016/j.rmed.2014.09.001. 2014
Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients.
Liapikou A; (...); Torres A
Article. 10.1183/09031936.00067111. 2012
Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors.
Méndez R; (...); Menéndez R
Article. 10.1111/joim.13262. 2021
Should ultrasound be included in the initial assessment of respiratory patients?
Ramirez P, Torres A
Editorial Material. 10.1016/S2213-2600(14)70142-0. 2014
Silver-embedded screens in the intensive care unit. A new tool to control multi-drug resistant bacterial cross-transmission
Ruiz J; (...); Castellanos Á
Article. 10.1007/s10096-017-2959-y. 2017
Simultaneous Depression of Immunological Synapse and Endothelial Injury is Associated with Organ Dysfunction in Community-Acquired Pneumonia
Menendez, R; (...); Bermejo-Martin, JE
Article. 10.3390/jcm8091404. 2019
Soluble P-Selectin in Acute Exacerbations and Stable Bronchiectasis in Adults
Mendez, R; (...); Menendez, R
Letter. 10.1513/AnnalsATS.201902-140RL. 2019
Soluble urokinase plasminogen activator receptor (suPAR) for the prediction of ventilator-associated pneumonia (VAP)
van Oort, PMP; (...); Martin-Loeches, I
Meeting Abstract. 10.1183/13993003.congress-2018.PA2607. 2018
Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia.
van Oort PM; (...); Martin-Loeches I
Article. 10.1183/23120541.00212-2018. 2019
Stability in community-acquired pneumonia: one step forward with markers?
Menéndez R; (...); Torres A
Article. 10.1136/thx.2009.118612. 2009
Starkeya nomas sp. nov., a prosthecate and budding bacterium isolated from an immunocompromized patient.
Sahuquillo-Arce JM; (...); López-Hontangas JL
Article. 10.1099/ijsem.0.005805. 2023
Streptococcus agalactiae in childbearing age immigrant women in Comunitat Valenciana (Spain)
Sahuquillo-Arce, JM; (...); Lopez-Hontangas, JL
Article. 10.1038/s41598-020-66811-2. 2020
Survival of nonagenarian patients admitted to the intensive care unit for symptomatic cardiac rhythm disturbances in need of a pacemaker.
PAULA RAMÍREZ GALLEYMORE; (...); Bonastre JM
Letter. 10.1111/j.1532-5415.2009.02294.x. 2009
Systemic Biomarkers in Bronchiectasis Exacerbations: A Comparison Between Hospitalized and Outpatients
Amara Elori, I.; (...); Menendez, R.
Meeting Abstract. 2018
Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcome.
Polverino E; (...); Torres A
Article. 10.1111/resp.12013. 2013
Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact ofPseudomonas aeruginosa
MENENDEZ, R; (...); Torres, A
Article. 10.3390/jcm9082631. 2020
Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study.
Wang X; (...); Barreiro E
Article. 10.3390/biomedicines10020225. 2022
Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD.
Crisafulli E; (...); Torres A
Article. 10.1378/chest.12-1684. 2013
Systemic inflammatory response and increased risk for ventilator-associated pneumonia: a preliminary study.
Ramírez P; (...); Torres A
Article. 10.1097/CCM.0b013e31819fec5f. 2009
Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review.
Candel, Francisco Javier; (...); Serrano, Leyre
Article. 10.3390/jcm12216864. 2023
Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review.
Candel, Francisco Javier; (...); Zaragoza, Rafael
Article. 10.3390/jcm12206526. 2023
Textbook outcome in patients with biliary duct injury during cholecystectomy.
Lopez-Lopez V; (...); Robles-Campos R
Article. 10.1016/j.gassur.2024.02.027. 2024
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.
Bermejo-Martin JF; (...); Kelvin DJ
Article. 10.1186/cc8208. 2009
The challenge of multiresistant microorganisms.
Vicent C, Ramírez P
Editorial Material. 10.1016/j.medcli.2023.12.004. 2024
The evolution and distribution of pneumococcal serotypes in adults hospitalized with community acquired pneumonia in Spain using serotype specific urinary antigen detection test: the CAPA study, 2011-2018.
Torres, Antoni; (...); Gessner, Bradford D
Article. 10.1093/cid/ciab307. 2021
The UK DCD Risk Score: Still no consensus on futility in DCD liver transplantation
Hessheimer, AJ; (...); Fondevila, C
Letter. 10.1016/j.jhep.2019.01.004. 2019
Thrombocytosis is a marker of poor outcome in community-acquired pneumonia.
Prina E; (...); Torres A
Article. 10.1378/chest.12-1235. 2013
Time-kill assays of amphotericin B plus anidulafungin against Candida tropicalis biofilms formed on two different biomaterials
Fernandez-Rivero, ME; (...); Canton, E
Article. 10.5301/ijao.5000652. 2018
Tobacco Smoking Increases the Risk for Death From Pneumococcal Pneumonia
Bello S; (...); Ruiz-Manzano J
Article. 10.1378/chest.13-2853. 2014
Training in Intensive Care Medicine. A challenge within reach
Castellanos-Ortega A; (...); Cuñat de la Hoz J
Article. 10.1016/j.medin.2013.12.011. 2014
Transcriptomic depression of immunological synapse as a signature of ventilator-associated pneumonia
Almansa, R; (...); Martin-Loeches, I
Article. 10.21037/atm.2018.05.12. 2018
Transcriptomics reveals shared immunosuppressive landscapes in ventilator-associated lower respiratory tract infections (VA-LRTI) patients.
Martin-Loeches I; (...); Bermejo-Martín JF
Article. 10.1080/14787210.2023.2256979. 2023
Treatment Failure and Clinical Stability in Severe Community-Acquired Pneumonia.
Méndez R; (...); Menéndez R
Article. 10.1055/s-0043-1778139. 2024
Treatment failure of hospitalized patients with COPD exacerbation using systemic corticosteroids plus antibiotics: Role of early inflammatory predictors
Crisafulli, Ernesto; (...); Torres, Antoni
Meeting Abstract. 2014
Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence.
Viale, Pierluigi; (...); Lodise, Thomas P.
Article. 10.1186/s13613-023-01146-5. 2023
Treatment of invasive fungal disease using anidulafungin alone or in combination for hematologic patients with concomitant hepatic or renal impairment
Montesinos P; (...); Sanz MÁ
Article. 10.1016/j.riam.2014.10.003. 2015
Tumor necrosis factor receptor 1 (TNFRI) for ventilator-associated pneumonia diagnosis by cytokine multiplex analysis.
Martin-Loeches I; (...); Artigas A
Article. 10.1186/s40635-015-0062-1. 2015
Understanding the Host in the Management of Pneumonia An Official American Thoracic Society Workshop Report
Dela Cruz, Charles S.; (...); Amer Thoracic Soc Assembly Pulm In
Article. 10.1513/AnnalsATS.202102-209ST. 2021
Update of the treatment of nosocomial pneumonia in the ICU
Zaragoza, R; (...); Martin-Loeches, I
Review. 10.1186/s13054-020-03091-2. 2020
Update on invasive candidiasis in non-neutropenic critically ill adult patients
Zaragoza R; (...); Pemán J
Review. 10.1016/j.riam.2016.03.001. 2016
Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease.
Lozano N; (...); Osuna A
Article. 10.1371/journal.pone.0282814. 2023
Usefulness of procalcitonin for diagnosing infection in critically ill patients with liver cirrhosis
Villarreal E; (...); Ramírez P
Article. 10.1016/j.medin.2015.02.006. 2016
UTILITY OF STREM-1 IN DIAGNOSING ETIOLOGY OF ARDS IN PATIENTS WITH ABDOMINAL PATHOLOGY
Ramirez, P.; (...); Pico, D.
Article. 2009
Validation of a Prediction Score for Drug-resistant Microorganisms in Community-Acquired Pneumonia.
Ceccato A; (...); Torres A
Article. 10.1513/AnnalsATS.202005-558OC. 2020
Validation of IDSA/ATS Guidelines for ICU Admission in Adults Over 80 Years Old With Community-Acquired Pneumonia.
Cilloniz, Catia; (...); Torres, Antoni
Article. 10.1016/j.arbres.2022.08.012. 2023
Validation of the PES Prediction Score for the Causative Different to Treat Microorganisms in Community-Acquired Pneumonia
Ceccato, A.; (...); Torres, A.
Meeting Abstract. 2020
Vancomycin and daptomycin minimum inhibitory concentrations as a predictor of outcome of methicillin-resistant Staphylococcus aureus bacteraemia
Ruiz, J; (...); Castellanos-Ortega, A
Article. 10.1016/j.jgar.2018.03.007. 2018
Vasopressin antagonist efficacy and safety in volume-overloaded critically ill patients: a new therapeutic alternative
Ruiz-Ramos, J; (...); Castellanos-Ortega, A
Article. 10.1136/ejhpharm-2018-001664. 2020
Ventilator-associated pneumonia by methicillin-susceptible Staphylococcus aureus: do minimum inhibitory concentrations to vancomycin and daptomycin matter?
Ruiz-Ramos, J; (...); Ramirez, P
Article. 10.1007/s10096-017-2970-3. 2017
Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19.
Bermejo-Martin JF; (...); Kelvin DJ
Article. 10.1186/s13054-020-03398-0. 2020
Análisis Epidemiológico, Clínico Y Microbiológico Del Brote De Candidiasis Invasora Por Candida Auris En El Hospital Universitario Y Politécnico La Fe
Autor/es: Alba Cecilia Ruiz Gaitán
Tesis Doctoral
Director/es: JAVIER PEMÁN GARCÍA; PAULA RAMÍREZ GALLEYMORE
Diploma De Estudios Avanzados. Análisis De La Alteración De La Permeabilidad Intestinal (Pi) En Pacientes Con Insuficiencia Cardíaca Crónica Reagudizada O Aguda Y Su Relación Con Marcadores Indirectos De Infección (Interleuquinas, Endotoxina Y Procalcitonina)
Autor/es: María Rosa Paños Melgoso
Tesis Doctoral
Director/es: PAULA RAMÍREZ GALLEYMORE
Diploma De Estudios Avanzados. Utilidad De Los Cultivos De Vigilancia Para La Predicción De La Etiología De La Neumonía Asociada A La Ventilación Mecánica. Aplicación En Una Uci Endémica Para Acinetobacter Baumannii Multirresistente.
Autor/es: Cristina López Ferraz
Tesis de Máster
Director/es: PAULA RAMÍREZ GALLEYMORE
Diploma De Estudios Avanzados.- Utilidad De La Procalcitonina En El Diagnóstico De La Infección Nosocomial Del Paciente Afecto De Accidente Cerebrovascular Grave.
Autor/es: Manuel Palomo Navarro
Tesis de Máster
Director/es: PAULA RAMÍREZ GALLEYMORE
Diploma De Estudios Avanzados.- Utilidad Del Soluble Triggrering Receptor Expressed On Myeloid Cells (Strem-1) En El Diagnóstico De La Ventriculitis Asociada A Drenajes Ventriculares
Autor/es: Monica Gordon Sahuquillo
Tesis de Máster
Director/es: PAULA RAMÍREZ GALLEYMORE
Diploma De Estudios Avanzados.análisis Del Comportamiento De La Procalcitonina En Los Pacientes Con Cirrosis Hepática Ingresados En Una Unidad De Cuidados Intensivos.
Autor/es: Esther Villarreal Tello
Tesis de Máster
Director/es: PAULA RAMÍREZ GALLEYMORE
Diploma De Estudios Avanzados.strem-1 In The Diagnosis Of Infection Site And Etiology Of Ards In Patients With Abdominal Pathology
Autor/es: Veronica Marti Alcarria
Tesis de Máster
Director/es: PAULA RAMÍREZ GALLEYMORE
Fisiopatogenia Y Diagnóstico De La Ventriculitis Asociada A Drenaje Ventricular Externo
Autor/es: Mónica Gordón Sahuquillo
Tesis Doctoral
Director/es: PAULA RAMÍREZ GALLEYMORE; PAULA RAMÍREZ GALLEYMORE; Soriano A
Campos de Estudio
Cita
HEALTH CARE ASSOCIATED PNEUMONIA (HCAP):MICROBIAL AETIOLOGY, RISK FACTORS AND PROGNOSTIC. (PI08/0123). INSTITUTO DE SALUD CARLOS III. 2009-2011. IP:ROSARIO MENÉNDEZ VILLANUEVA.